The company
Ollie's Bargain Outlet Holdings, Inc.
OLLI · Nasdaq
OLLI stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 15.3% above that average now. Mass, Grocery & Drug Retail: 31% of its 26 stocks in an uptrend (±0 points in four weeks); Consumer Staples: 24% (+1 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 31% 0 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $2.6M
- Officials’ trades on record
- 32
- Institutions holding
- 420 (-16)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Mass, Grocery & Drug Retail: A minority of its stocks are in an uptrend and the share has held steady. Consumer Staples: A minority of its stocks are in an uptrend and the share has held steady.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
32 disclosed lines: House 23, Senate 6, executive 3; 7 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 28 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 17 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 26 Mar 2026filed 14 May 2026 |
| Markwayne Mullin Senate: U.S. Senate eFDSenator | soldspouse | $15k–$50k | 18 Dec 2024filed 31 Dec 2024 |
| Markwayne Mullin Senate: U.S. Senate eFDSenator | sold | $15k–$50k | 18 Dec 2024filed 31 Dec 2024 |
| Markwayne Mullin Senate: U.S. Senate eFDSenator | boughtspouse | $1k–$15k | 4 Jan 2024filed 12 Aug 2025 |
| Markwayne Mullin Senate: U.S. Senate eFDSenator | bought | $1k–$15k | 4 Jan 2024filed 12 Aug 2025 |
| Markwayne Mullin Senate: U.S. Senate eFDSenator | boughtspouse | $1k–$15k | 4 Jan 2024filed 26 Jan 2024 |
| Markwayne Mullin Senate: U.S. Senate eFDSenator | bought | $1k–$15k | 4 Jan 2024filed 26 Jan 2024 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 4 Mar 2022filed 17 Apr 2022 |
| Lois Frankel House: U.S. House ClerkFL21 | sold | $1k–$15k | 11 Jan 2022filed 16 Feb 2022 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | bought | $1k–$15k | 10 Jan 2022filed 18 Feb 2022 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| John W. SwygertExecutive Chairman | sold | 3,330at $95.80 | 7 Apr 2026filed 8 Apr 2026 |
| John W. SwygertExecutive Chairman | sold | 5,231at $92.09 | 31 Mar 2026filed 2 Apr 2026 |
| John W. SwygertExecutive Chairman | sold | 3,898at $89.40 | 27 Mar 2026filed 27 Mar 2026 |
| John W. SwygertExecutive Chairman | sold | 1,126at $112.06 | 9 Feb 2026filed 11 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| FMR LLCadded · filed 13 Aug 2026 | 8,762,326$673.6M | +1,997,151+29.5% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 5,595,790$430.2M | -11,133−0.2% |
| WASATCH ADVISORS LPadded · filed 10 Jul 2026 | 4,362,067$335.4M | +1,371,744+45.9% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 2,734,735$210.2M | -19,360−0.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,545,897$195.7M | +8,113+0.3% |
| Capital Research Global Investorsadded · filed 12 Aug 2026 | 2,422,774$186.3M | +1,055,023+77.1% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 1,986,882$152.8M | +77,888+4.1% |
| DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 2026 | 1,734,053$133.3M | +461,747+36.3% |
| Summit Trail Advisors, LLCadded · filed 11 Aug 2026 | 1,612,868$124.0M | +10,718+0.7% |
| Point72 Asset Management, L.P.added · filed 14 Aug 2026 | 1,511,974$116.2M | +469,091+45.0% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.